{
    "title": "Bristol Myers says it needs another year to hit target for new drugs",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12675457/Bristol-Myers-says-needs-year-hit-target-new-drugs.html",
    "date": "2023-10-26",
    "keywords": [
        "company",
        "drug",
        "share",
        "year",
        "quarter",
        "cancer",
        "erman",
        "roy",
        "newproduct",
        "portfolio",
        "revenue",
        "treatment",
        "sotyktu",
        "drugmaker",
        "officer",
        "boerner",
        "forecast",
        "competition",
        "bristol",
        "blood",
        "thursday",
        "time",
        "frame",
        "rampup",
        "psoriasis",
        "sclerosis",
        "zeposia",
        "morning",
        "potential",
        "david",
        "interview",
        "pace",
        "chief",
        "christopher",
        "ceo",
        "change",
        "manufacturing",
        "cell",
        "therapy",
        "abecma",
        "analyst",
        "health",
        "insurance",
        "coverage",
        "reblozyl",
        "average",
        "end",
        "range",
        "month",
        "giovanni",
        "caforio",
        "princeton",
        "revlimid",
        "immunotherapy",
        "opdivo",
        "thinner",
        "patent",
        "protection",
        "decade",
        "mirati",
        "attempt",
        "oncology",
        "business",
        "reporting",
        "editing",
        "adler",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}